Note: While these antioxidants are generally well-tolerated, it is always a good idea to consult with your healthcare provider before starting a new routine, especially if you are pregnant, nursing, or taking prescription medications
Then, gradual dosage increases are tailored for you individually based on your progress, your goals and how your body is responding to the prescription
Novo Nordisk maintains first-to-market advantage with semaglutide across diabetes (Ozempic), obesity (Wegovy), and oral (Rybelsus) formulations, with the oral version launching in January 2026 following December 2025 FDA approval [3]
I think thats just part of the inherent bias towards the treatment of people with obesity
Anxiety can deepen the same loop, since excessive worry often brings muscle tension, restlessness, and trouble concentrating, symptoms detailed by the Mayo Clinic in its guide to generalized anxiety disorder